Canale, Matteo

Impact of TP53 Mutations on Outcome in EGFR -Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors

Canale, M., Petracci, E., Delmonte, A., Chiadini, E., Dazzi, C., Papi, M., Capelli, L., Casanova, C., De Luigi, N., Mariotti, M., et al. (2017) · Clinical Cancer Research

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 288

Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

Bilbao, I., Recalde, M., Daian, F., Herranz, J. M., Elizalde, M., Iñarrairaegui, M., Canale, M., Fernández-Barrena, M. G., Casadei-Gardini, A., Sangro, B., et al. (2024) · Journal of Physiology and Biochemistry

Epigenetics and DNA MethylationCancer-related molecular mechanisms research

Cited by 0